Literature DB >> 32944830

Bacterial diversity and inflammatory response at first-time visit in younger and older individuals with diabetic foot infection (DFI).

Stefan Dörr1, Florian Freier2, Michael Schlecht2, Ralf Lobmann3.   

Abstract

AIM: Infection of a diabetic foot ulcer (DFU) is common. More than the half of DFUs become infected and 15-20% of them necessitate amputation in course of treatment. Diabetic foot infection (DFI) is therefore the major cause for non-traumatic lower limb amputation in Germany. Prompt and effective treatment of DFI is mandatory to safe limbs and lives. We investigated if there are relevant differences in evoked inflammatory response between different species and age-separated groups. We further investigated if there is an impact of ulcer localization on bacterial diversity.
METHODS: For a 12-month period, we investigated 353 individuals with infected DFU, their laboratory results and bacterial diversity at first-time visit in a Diabetic Foot Care Center in Southern Germany.
RESULTS: The ulcer microbiota was dominated by gram-positive species, primary Staphylococcus aureus. The gram-negative sector was mainly formed by Pseudomonas aeruginosa and Enterobacteriaceae (Proteus spp., Enterobacter spp., Escherichia coli and Klebsiella spp.). With increase in age, P. aeruginosa and S. aureus became more frequent, while Streptococci decreased. Ischemic and/or deep wounds were more likely to bear gram-negative species. Inflammatory response did not differ between gram-positive and gram-negative species, while Streptococci and Proteus spp. induced the highest serum inflammation reaction in their category. Streptococci, Enterobacter spp. and E. coli were more frequent in summer, while Enterococci spp., coagulase-negative Staphylococci and P. aeruginosa were more prevalent in winter half-year. DFIs of the forefoot and plantar side are mostly caused by gram-positive species, while Enterobacteriaceae were most frequent in plantar ulcerations.
CONCLUSION: Gram-positive species dominate bacterial spectrum in DFI. With increase in age, S. aureus, Streptococci and Pseudomonas aeruginosa became more frequent. The inflammatory response did not differ significantly between different species, but gram-negative species were slightly but not significant more frequent in ischemic wounds. Climatic distinction like summer or winter half-year as well as foot ulcer localization seems to influence bacterial diversity in DFUs.

Entities:  

Keywords:  Diabetic foot infection; Diabetic foot ulcer; Inflammatory response; Microbiology; Microbiota

Year:  2020        PMID: 32944830     DOI: 10.1007/s00592-020-01587-5

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  4 in total

Review 1.  Microbial Infection and Antibiotic Susceptibility of Diabetic Foot Ulcer in China: Literature Review.

Authors:  Fang Du; Jing Ma; Hongping Gong; Raju Bista; Panpan Zha; Yan Ren; Yun Gao; Dawei Chen; Xingwu Ran; Chun Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

2.  The Antimicrobial Effects of Bacterial Cellulose Produced by Komagataeibacter intermedius in Promoting Wound Healing in Diabetic Mice.

Authors:  Chou-Yi Hsu; Sheng-Che Lin; Yi-Hsuan Wu; Chun-Yi Hu; Yung-Tsung Chen; Yo-Chia Chen
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

3.  Microbiology of Diabetic Foot Infections in a Tertiary Care Hospital in São Paulo, Brazil.

Authors:  Amanda Thurler Palomo; Ana Paula Maia Pires; Marcelo Fernando Matielo; Rafael de Athayde Soares; Christiano Pecego; Roberto Sacilotto; Alexandre Inacio de Paula; Nair Hosino; Cristiano de Melo Gamba; Cibele Lefreve Fonseca; Daniela K S Paraskevopoulos; Augusto Yamaguti; João Silva de Mendonça; Silvia Figueiredo Costa; Thaís Guimarães
Journal:  Antibiotics (Basel)       Date:  2022-08-19

Review 4.  Bioactive Antimicrobial Peptides as Therapeutic Agents for Infected Diabetic Foot Ulcers.

Authors:  Jessica Da Silva; Ermelindo C Leal; Eugénia Carvalho
Journal:  Biomolecules       Date:  2021-12-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.